Cargando…

Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification

BACKGROUND: Fluoroquinolone resistant E. coli isolates, that are also resistant to other classes of antibiotics, is a significant challenge to antibiotic treatment and infection control policies. In Central Greece a significant increase of ciprofloxacin-resistant Escherichia coli has occurred during...

Descripción completa

Detalles Bibliográficos
Autores principales: Mavroidi, Angeliki, Miriagou, Vivi, Liakopoulos, Apostolos, Tzelepi, Εva, Stefos, Angelos, Dalekos, George N, Petinaki, Efthymia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548683/
https://www.ncbi.nlm.nih.gov/pubmed/23259844
http://dx.doi.org/10.1186/1471-2334-12-371
_version_ 1782256345985056768
author Mavroidi, Angeliki
Miriagou, Vivi
Liakopoulos, Apostolos
Tzelepi, Εva
Stefos, Angelos
Dalekos, George N
Petinaki, Efthymia
author_facet Mavroidi, Angeliki
Miriagou, Vivi
Liakopoulos, Apostolos
Tzelepi, Εva
Stefos, Angelos
Dalekos, George N
Petinaki, Efthymia
author_sort Mavroidi, Angeliki
collection PubMed
description BACKGROUND: Fluoroquinolone resistant E. coli isolates, that are also resistant to other classes of antibiotics, is a significant challenge to antibiotic treatment and infection control policies. In Central Greece a significant increase of ciprofloxacin-resistant Escherichia coli has occurred during 2011, indicating the need for further analysis. METHODS: A total of 106 ciprofloxacin-resistant out of 505 E. coli isolates consecutively collected during an eight months period in a tertiary Greek hospital of Central Greece were studied. Antimicrobial susceptibility patterns and mechanisms of resistance to quinolones were assessed, whereas selected isolates were further characterized by multilocus sequence typing and β-lactamase content. RESULTS: Sequence analysis of the quinolone-resistance determining region of the gyrA and parC genes has revealed that 63% of the ciprofloxacin-resistant E. coli harbored a distinct amino acid substitution pattern (GyrA:S83L + D87N; ParC:S80I + E84V), while 34% and 3% carried the patterns GyrA:S83L + D87N; ParC:S80I and GyrA:S83L + D87N; ParC:S80I + E84G respectively. The aac (6’)-1b-cr plasmid-mediated quinolone resistance determinant was also detected; none of the isolates was found to carry the qnrA, qnrB and qnrS. Genotyping of a subset of 35 selected ciprofloxacin-resistant E. coli by multilocus sequence typing has revealed the presence of nine sequence types; ST131 and ST410 were the most prevalent and were exclusively correlated with hospital and health care associated infections, while strains belonging to STs 393, 361 and 162 were associated with community acquired infections. The GyrA:S83L + D87N; ParC:S80I + E84V substitution pattern was found exclusively among ST131 ciprofloxacin-resistant E. coli. Extended-spectrum β-lactamase-positive ST131 ciprofloxacin-resistant isolates produced CTX-M-type enzymes; eight the CTX-M-15 and one the CTX-M-3 variant. CTX-M-1 like and KPC-2 enzymes were detected in five and four ST410 ciprofloxacin-resistant E. coli isolates, respectively. CONCLUSIONS: Our findings suggest that, ST131 and ST410 predominate in the ciprofloxacin resistant E. coli population.
format Online
Article
Text
id pubmed-3548683
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35486832013-02-04 Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification Mavroidi, Angeliki Miriagou, Vivi Liakopoulos, Apostolos Tzelepi, Εva Stefos, Angelos Dalekos, George N Petinaki, Efthymia BMC Infect Dis Research Article BACKGROUND: Fluoroquinolone resistant E. coli isolates, that are also resistant to other classes of antibiotics, is a significant challenge to antibiotic treatment and infection control policies. In Central Greece a significant increase of ciprofloxacin-resistant Escherichia coli has occurred during 2011, indicating the need for further analysis. METHODS: A total of 106 ciprofloxacin-resistant out of 505 E. coli isolates consecutively collected during an eight months period in a tertiary Greek hospital of Central Greece were studied. Antimicrobial susceptibility patterns and mechanisms of resistance to quinolones were assessed, whereas selected isolates were further characterized by multilocus sequence typing and β-lactamase content. RESULTS: Sequence analysis of the quinolone-resistance determining region of the gyrA and parC genes has revealed that 63% of the ciprofloxacin-resistant E. coli harbored a distinct amino acid substitution pattern (GyrA:S83L + D87N; ParC:S80I + E84V), while 34% and 3% carried the patterns GyrA:S83L + D87N; ParC:S80I and GyrA:S83L + D87N; ParC:S80I + E84G respectively. The aac (6’)-1b-cr plasmid-mediated quinolone resistance determinant was also detected; none of the isolates was found to carry the qnrA, qnrB and qnrS. Genotyping of a subset of 35 selected ciprofloxacin-resistant E. coli by multilocus sequence typing has revealed the presence of nine sequence types; ST131 and ST410 were the most prevalent and were exclusively correlated with hospital and health care associated infections, while strains belonging to STs 393, 361 and 162 were associated with community acquired infections. The GyrA:S83L + D87N; ParC:S80I + E84V substitution pattern was found exclusively among ST131 ciprofloxacin-resistant E. coli. Extended-spectrum β-lactamase-positive ST131 ciprofloxacin-resistant isolates produced CTX-M-type enzymes; eight the CTX-M-15 and one the CTX-M-3 variant. CTX-M-1 like and KPC-2 enzymes were detected in five and four ST410 ciprofloxacin-resistant E. coli isolates, respectively. CONCLUSIONS: Our findings suggest that, ST131 and ST410 predominate in the ciprofloxacin resistant E. coli population. BioMed Central 2012-12-23 /pmc/articles/PMC3548683/ /pubmed/23259844 http://dx.doi.org/10.1186/1471-2334-12-371 Text en Copyright ©2012 Mavroidi et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Mavroidi, Angeliki
Miriagou, Vivi
Liakopoulos, Apostolos
Tzelepi, Εva
Stefos, Angelos
Dalekos, George N
Petinaki, Efthymia
Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification
title Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification
title_full Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification
title_fullStr Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification
title_full_unstemmed Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification
title_short Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification
title_sort ciprofloxacin-resistant escherichia coli in central greece: mechanisms of resistance and molecular identification
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548683/
https://www.ncbi.nlm.nih.gov/pubmed/23259844
http://dx.doi.org/10.1186/1471-2334-12-371
work_keys_str_mv AT mavroidiangeliki ciprofloxacinresistantescherichiacoliincentralgreecemechanismsofresistanceandmolecularidentification
AT miriagouvivi ciprofloxacinresistantescherichiacoliincentralgreecemechanismsofresistanceandmolecularidentification
AT liakopoulosapostolos ciprofloxacinresistantescherichiacoliincentralgreecemechanismsofresistanceandmolecularidentification
AT tzelepieva ciprofloxacinresistantescherichiacoliincentralgreecemechanismsofresistanceandmolecularidentification
AT stefosangelos ciprofloxacinresistantescherichiacoliincentralgreecemechanismsofresistanceandmolecularidentification
AT dalekosgeorgen ciprofloxacinresistantescherichiacoliincentralgreecemechanismsofresistanceandmolecularidentification
AT petinakiefthymia ciprofloxacinresistantescherichiacoliincentralgreecemechanismsofresistanceandmolecularidentification